您现在的位置:首页 > 新闻动态 >全部
Annexin V, FITC Apoptosis Detection Kit文献索引 (2019-8-13)
 Annexin V, FITC Apoptosis Detection Kit文献索引

文献

No

文献

IF

1

Chen Qi,et al.,Anti-mitotic chemotherapeutics promote apoptosis through TL1A-activated death receptor 3 in cancer cells,Cell Research, 2018,28,544 – 555

2018

15

2

Piao Zhu,et al.,Nanoenzyme-Augmented Cancer Sonodynamic Therapy by Catalytic Tumor Oxygenation,ACS Nano,2018,12(4),3780-3795

2018

13.9

3

Wenfei Chen,et al.,Bacteria-Driven Hypoxia Targeting for Combined Biotherapy and Photothermal Therapy, ACS Nano,2018,12 (6), pp 5995–6005

2018

13.9

4

Yachao Li,et al.,Tumor-Specific Multiple Stimuli-Activated Dendrimeric Nanoassemblies with Metabolic Blockade Surmount Chemotherapy Resistance,
ACS Nano,2017,11(1),416-429.

2017

13.9

5

Penghui Zhang,et al.,Near Infrared-Guided Smart Nanocarriers for MicroRNA-Controlled Release of Doxorubicin/siRNA with Intracellular ATP as Fuel,
ACS Nano,2016,10(3),3637-47

2016

13.9

6

Nanoenzyme-Augmented Cancer Sonodynamic Therapy by Catalytic Tumor Oxygenation,ACS Nano,2018, 12, 37803795

2018

13.9

7

Lai J,et al.,Noninvasive small-animal imaging of galectin-1 upregulation for predicting tumor resistance to radiotherapy,Biomaterials, 2018,158,1-9

2018

10.2

8

Nan Zhang,et al., Cytotoxicity of guanine-based degradation products contributes to the antiproliferative activity of guanine-rich oligonucleotides,
Chemical Science,2015,6,3834-3836

2015

9.5

9

Xingli Cun, et al., A Novel Strategy through Combining iRGD Peptide with Tumor-Microenvironment-Responsive and Multistage Nanoparticles for Deep Tumor Penetration, ACS Appl.Mater.Interfaces, 2015,7 (49),27458–27466

2015

8.4

10

Yizhe Sun,et al., TMEM74 promotes tumor cell survival by inducing autophagy via interactions with ATG16L1 and ATG9A, Cell Death and Disease,2017, 8, e3031-3045

2017

5.9

11

Shi Jia,et al.,Nogo-C regulates cardiomyocyte apoptosis during mouse myocardial infarction, Cell Death and Disease,2016,7,e2432

2016

5.9

12

Giuseppa Augello,et al.,Preclinical evaluation of antitumor of the proteasome inhibitor MLN2238 (ixazomib) in hepatocellular carcinoma cells,Cell Death and Disease,2018,9,28

2018

5.9